Fig. 5From: Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?Example of thoracic CT in immune-related pneumonitis. The patient had been treated for NSCLC with pembrolizumab for 2 months. He developed acute respiratory failure. CT showed the typical organizing pneumonia patternBack to article page